Wiley Bros. Aintree Capital, LLC Charles River Laboratories International, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $8.04 Billion
- Q4 2024
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 7,617 shares of CRL stock, worth $1.16 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,617
Previous 6,003
26.89%
Holding current value
$1.16 Million
Previous $1.18 Million
18.95%
% of portfolio
0.02%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding CRL
# of Institutions
703Shares Held
52.8MCall Options Held
157KPut Options Held
413K-
Vanguard Group Inc Valley Forge, PA6.16MShares$936 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$773 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$620 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$332 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$275 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.73B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...